Deborah Offers Surgical and Nonsurgical Interventional Treatments for Vascular Disease
Vascular specialists and surgeons at Deborah Heart and Lung Center are currently offering surgical and nonsurgical interventional procedures, allowing for treatment of vascular disease from its most mild to most critical stages. Including balloon, stent, and Rotablator interventions and the latest in surgical treatment approaches, these procedures afford physicians the opportunity to treat patients at any stage of the disease.
Rodolfo Pascual, MD, William Rough, MD, and Jeffrey Hager, DO, Vascular Surgery Program Director, perform vascular surgery at Deborah Heart and Lung Center, surgically treating patients in one of the Center's five operating suites. Nearly 400 procedures are performed annually, the most common of which are carotid endarterectomies, abdominal aortic aneurysm resections and lower extremity revascularizations.
Patients in Deborah's new Comprehensive Vascular Program are referred for surgery when disease has progressed beyond nonsurgical treatment methods, when the patient is at risk for stroke or when severe disease in lower extremities is causing constant pain or posing a threat to limb viability. All patients are evaluated by Deborah's cardiologists prior to surgery to determine the risk of coexisting coronary artery disease. If atherosclerosis is found in coronary arteries, the patient's surgeries can be performed either simultaneously or staged, according to the severity of the blockages.
"Because of the strong relationship between vascular disease and coronary artery disease, each vascular surgery patient at Deborah is first screened for coexistent coronary artery disease," said Dr. Hager. "If it is determined that a patient has atherosclerosis in the coronary arteries as well as the peripheral vessels, we can often offer them the option to have both conditions corrected at once, ultimately reducing hospital stay and recovery time."
According to Dr. Hager, atherosclerosis in the legs is treated differently than in the arteries of the neck. Symptoms of carotid atherosclerosis or aortic atherosclerosis can result in stroke or aneurysm, while the main symptom in the leg is pain, which can often be treated nonsurgically and is not typically life-threatening. Vascular surgeons will treat patients with iliac or femoral blockages first with medications and/or walking programs to increase a patient's level of pain-free activity. Then, if patients are determined to be candidates and are willing, nonsurgical intervention may be attempted. Only after the disease has progressed beyond these methods, or when a patient is suffering from limb-threatening ischemia, will the vascular team recommend a surgical bypass procedure. According to Dr. Hager, surgery is deferred because many patients can be successfully treated for years without surgery, and also because patency rates of femoral bypass surgeries can be inconsistent, and further interventions may eventually be needed.
|

"Because of the length of the grafts required for most femoral bypass surgeries, it is possible that grafts may occlude," said Dr. Hager. "Therefore, we monitor postoperative patients very closely, so any blockages in grafts will be found immediately and proper action will be taken."
All of Deborah's vascular surgery patients are followed frequently within the first year of surgery, beginning only a few weeks after the procedure. At one, three and six months postoperatively, the conditions of both surgical wounds and restored blood flow are evaluated, and, biannually, patients return through Deborah's Ambulatory Care Clinic to be monitored for new or recurring blockages. Physicians in Deborah's Comprehensive Vascular Program are currently working to establish a postoperative surveillance program, which will also help monitor patients after surgery.
In addition to surgical treatments, Deborah offers numerous nonsurgical interventions to treat vascular disease in the Center's Radiology Special Procedures Suite, in which interventionalists and radiologists collaborate to treat vascular patients nonsurgically.
"Vascular patients at Deborah can now take advantage of nonsurgical treatments for vascular disease," said Manu Rajachandran, MD, Medical Director of the Comprehensive Vascular Program. "If medications or walking therapy are not effective, or if they are referred to the program with disease that has progressed beyond noninvasive treatment methods, patients can often undergo a short, minimally-invasive procedure to relieve their symptoms."
|
Dr. Rajachandran, who completed a full year of rigorous vascular interventional training and one year of coronary interventional training prior to beginning practice, provides the opportunity for patients to nonsurgically combat vascular disease, with procedures like balloon angioplasty, stent placement, laser and Rotablator interventional techniques. Each interventional procedure will use some or all of these modalities to reopen the occluded artery and restore blood flow.
"We are modifying the disease process in qualified patients who choose to undergo nonsurgical interventional procedures, the results of which are proving to be durable in the long-term," said Dr. Rajachandran. "We are now able to treat patients early in the course of their symptoms and disease, often obviating, or delaying, the need for surgery." Deborah physicians collaborate to tailor the patient's vascular needs to the most appropriate interventional or surgical procedure. The goal of the program is to foster a synergistic approach to the treatment of vascular disease.
"This collaboration is a primary aspect of Deborah's Comprehensive Vascular Program," said Dr. Rajachandran. "With the surgeon, interventionist, cardiologist and radiologist working together to best treat each vascular patient, the patients are guaranteed the expertise of physicians in each area of the Program. From prevention to surgery, we offer the full spectrum of care for patients in any stage of disease progression, from one of the premier Centers of excellence in the region."
Manu Rajachandran, MD., Medical Director, Comprehensive Vascular Program.
|